Total Body Irradiation (TBI): Migrating from Linac Based Open Field Technique to TomoTherapy®
Join Dr. Deepak Gupta as he explores the role of Total Body Irradiation (TBI) in the treatment of hematologic malignancies. The objective of this webinar is to explain the background & rationale of treatment, clinical application, and clinical experiences utilizing TomoTherapy®/Radixact® Treatment Systems. Dr. Gupta will share the experience of the Medanta Cancer Institute, TBI TomoTherapy program.
CyberKnife® Radiosurgery for Brainstem Lesions
During this webinar, “CyberKnife Radiosurgery for Brainstem Lesions”, Dr. Wang will present SRS, hypofractionated stereotactic radiosurgery, and staged SRS for the brain stem lesions from brain metastasis, glioma to cavernous hemangioma, etc with Huashan CyberKnife Center’s experiences. The objective is to share the efficacy and safety with CyberKnife for brainstem lesions treatment.
Ultra-Hypofractionated Partial Breast Radiotherapy
The webinar will focus on ultra-hypofractionated partial breast radiotherapy. Outcomes, ongoing trials, and future trends in accelerated partial breast irradiation (APBI) will be presented by Frank Vicini, M.D. Asal Rahimi, M.D. will share her clinical experience of Stereotactic Body Radiation Therapy (SBRT) for APBI. Mark Perman, M.D. and Debra Freeman, M.D. will share information on the protocol and data collection for the Registry for Performance and Clinical Outcomes in Radiosurgery (RPCR) APBI and Breast SBRT.
Stereotactic Body Radiotherapy for Spinal Metastasis: an Overview of Doses and Fractionation
The webinar will focus on the dose and fractionation of spine SBRT referring to the latest published studies. Primary SBRT and reirradiation will be addressed, as well as recent data on doses/fractionation. Case reports will be shared demonstrating clinical and technical aspects of spinal SBRT delivery.
TomoTherapy® in Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is highly prevalent in southeast of Asia, and it is predominantly treated by radiotherapy (RT). Intensity-modulated RT (IMRT) exhibits better dosimetric advantages over two-dimensional RT (2D-RT) or three-dimensional conformal RT (3D-CRT). It has significantly improved the local control rate of NPC and reduced acute and chronic toxicities. Helical TomoTherapy® was an emerging technology that integrates IMRT, image-guided intensity modulated radiotherapy (IGRT) and dose-guided intensity modulated radiotherapy (DGRT). TomoTherapy makes a perfect combination of linear accelerator and helical CT, breaking through many limitations of traditional accelerator. While rotating the irradiation target area, the treatment couch advances axially through the center of the stand, which is used to treat tumors efficiently and accurately. This webinar will focus on the treatment of NPC by TomoTherapy. Firstly, describing the therapeutic mechanism of TomoTherapy, the advantages and limitations of TomoTherapy in the treatment of tumors. This webinar will explain how to implement TomoTherapy in a patient with NPC. Finally, the experience of treating NPC by TomoTherapy in the Sun Yat-sen University Cancer Center, Guangzhou, China will be shared.
Prostate SBRT and the PACE-B trial
Define the current best practice for prostate Stereotactic Body Radiation Therapy (SBRT). Describe the evidence underpinning prostate SBRT practice. Discuss the recently released data from the international PACE-B trial, which randomized patients between standard fractionation radiotherapy and five fraction SBRT.
25 Years of SBRT with CyberKnife
Dr. Anand Mahadevan is the Professor and Chairman of Radiation Oncology and Dr. Jimm Grimm is the Lead CyberKnife Physicist at Geisinger Medical Center.
Glioblastoma re-irradiation with the CyberKnife® System
“Because most patients with glioblastoma (GBM) will recur, mainly within the first radiation therapy (RT) volume, consequently the question of re-RT, post or instead of reoperation, is critical in our daily practice. As there is no standard in this situation of first recurrence, it seems relevant to share and exchange with the neuro-oncologic community about our 10-year experience of GBM re-irradiation, with and without concomitant Bevacizumab, particularly with the CyberKnife system, which holds in our opinion a very unique place.”
New Evidence for Hepatocellular Carcinoma SBRT Treatment with the CyberKnife® System
In this webinar Dr. Song will discuss how survival outcomes for patients with small-sized hepatocellular carcinoma undergoing SBRT are comparable to those following surgical resection and radiofrequency ablation, and how SBRT could be a bridging therapy for hepatocellular carcinoma prior to liver transplantation.
TomoTherapy® based dose-escalated radiation therapy for painful bone metastases using the Scan-Plan-QA-Treat workflow
In this webinar, Drs. Muller and Wijesooriya will discuss their experience with same day simulation, planning, and treatment of painful osseous metastases with dose escalated radiation therapy using the TomoTherapy platform. They will also discuss the prospective trials, and the workflow performed at the University of Virginia. The session will be moderated by Dr. Paul Read.